Oncolab: Funding, Investors & Team (Sep 2026)
Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.
Oncolab has raised $680k across 1 funding round on record, the most recent a Seed of $680k announced in Nov 2025.
That round is below the $12M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oncolab Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Oncolab Funding Rounds
Oncolab Founders and Leadership Team
Contact details for the Oncolab team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Oncolab Funding Compared to Other Biotechnology Startups
Oncolab's latest round of $680k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oncolab in Biotechnology and Cheongju
Companies Similar to Oncolab
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Reprogenix is a groundbreaking medical technology firm
Rion Vet mission is to drive the regenerative medicine revolution.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal…
iOrganBio is a pioneering cell production platform.
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
Oncolab Funding FAQs
What does Oncolab do?
Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.
How much funding has Oncolab raised?
Oncolab has raised $680k across 1 round on record. The most recent is a Seed of $680k announced in Nov 2025.
When did Oncolab last raise funding?
Oncolab's most recent funding round on record is a Seed of $680k, announced in Nov 2025.
Where is Oncolab headquartered?
Oncolab is based in Cheongju, South Korea.
How many employees does Oncolab have?
Oncolab is in the 1-10 employee band.
How does Oncolab's funding compare to other Biotechnology startups?
Oncolab's latest round of $680k is below the $12M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's Oncolab Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oncolab is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.